Immunovant, Inc. (IMVT)
25.35
-0.26
(-1.02%)
USD |
NASDAQ |
Dec 30, 16:00
25.33
-0.02
(-0.08%)
After-Hours: 20:00
Immunovant Shareholders Equity (Quarterly): 519.70M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Revvity, Inc. | 7.376B |
| Viridian Therapeutics, Inc. | 502.97M |
| Perspective Therapeutics, Inc. | 242.22M |
| Electromed, Inc. | 44.74M |
| Xtant Medical Holdings, Inc. | 50.38M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 582.96M |
| Total Liabilities (Quarterly) | 63.25M |
| Current Ratio | 9.067 |
| Net Debt Paydown Yield | 0.00% |